Biogen's $15 Billion Alzheimer's Surge Tarnishes FDA

Bookmark
(Bloomberg Opinion) -- It’s hard to focus on anything besides the election and pandemic. But one of the most important drug debates in years is taking place this week, and it has nothing to do with...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.